Provider review
Rx Com review: it names the pharmacy, the street and the doctors, and makes one loose promise about your weight
Two questions almost nothing in this market answers: who fills my prescription, and can I take it somewhere else? Rx Com answers both, in its own terms, with a pharmacy name, a street address and a phone number — and a line saying you may send the prescription to any pharmacy you like. Its weight-loss page quotes no percentage and no before-and-after. The one weight promise on the site, "Lose pounds of fat every week" at the top of the signup page, reaches past what the trials measured. The loudest numbers on the site belong to a discount card that has nothing to do with the drug.
Some links on this site are affiliate links, and we may earn a commission. How we’re paid
Visit Rx ComOf Rx Com’s 2 dated product claims documented below, 2 are consistent with the cited evidence. Among the dated prices documented below, the lowest listed upfront charge is $175 for 30 days (Compounded semaglutide injection, one month). A matching claim does not mean the compounded product was tested or FDA-approved.
Names the pharmacy, its street and the clinical network; its only weight promise, "lose pounds of fat every week", runs past the trials.
Worth trusting if
- You want to know which pharmacy fills your prescription, and to look it up before you pay
- You want the option of sending the prescription to your own pharmacy instead
- You want a seller that describes the drug rather than quoting you a percentage
Be skeptical if
- You want published evidence beside the claims, because no trial is named anywhere on the site
- You want to know whether your medication is made to order or dispensed ready-made
- You arrived from the discount card, whose percentages have nothing to do with this program
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Compounded
Phase 3 trials
Named
None found
Provenance
Products reviewed at Rx Com
These evidence cards classify the treatments evaluated in this review. Confirm the exact medicine and formulation proposed for your prescription with the care team.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide injection — $175 for a single month; the advertised $99 needs twelve months paid at once, and $146 needs six.
- Compounded tirzepatide injection — $285 for a single month; the advertised $149 needs twelve months paid at once, and $259 needs six.
Evidence
Has the molecule been tested for what it is sold for?
Each row summarizes human evidence for the molecule and the use being advertised. Results apply to the product, dose, population and outcome studied; they do not establish that this provider’s preparation or program produces the same results. Compounded drugs are not FDA-approved. Evidence for one use should not be assumed to support another.
2
Products with human evidence
For the advertised use, out of 2 products reviewed here. The evidence concerns the molecule, not Rx Com's service.
2
Registry records cited
Distinct ClinicalTrials.gov records cited across the reviewed products. Registration alone does not establish that a treatment works.
The comparison
What they claim, against what the trials show
Each claim below is quoted word for word from Rx Com’s own page. Tap a row to see the quote, the trials behind it, and why it got that verdict.
Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim matches the trials
“The most widely used GLP-1. Gradual, effective results. […] Same price at every dose. We never charge by strength. Your provider sets and adjusts your dose (0.25 mg to 2.4 mg); your price stays the same.”
Read on the Rx Com site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, titrated to semaglutide 2.4 mg — the same ceiling Rx Com names on its own page. Reported a mean weight reduction of about 15%.
Beyond "gradual, effective results", the semaglutide copy says nothing about what the drug will do to your weight, so there is no number to weigh. What it does say about the molecule is factually careful in a way that is easy to miss: the dose range it publishes, 0.25 mg to 2.4 mg, is exactly the ladder STEP 1 titrated participants along, ending at the 2.4 mg maintenance dose the trial measured. A seller quoting a ceiling that matches the trial is a small thing and a good sign, because the common failure is an advertised price pegged to a starting dose with no ladder published above it. The description of semaglutide as the most widely used GLP-1 is a market claim rather than a clinical one and is not graded here.1
Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim matches the trials
“Dual-action. Largest average loss in clinical trials. […] Same price at every dose. We never charge by strength. Your provider sets and adjusts your dose (2.5 mg to 15 mg); your price stays the same.”
Read on the Rx Com site, September 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly, from a 2.5 mg starting dose. Reported a mean reduction of roughly 20% at the top dose — the largest published for an approved medicine in this class.
Two claims here and both survive. "Dual-action" — the weight-loss page spells it out as working "on both GLP-1 and GIP receptors" — is a correct description of the molecule. "Largest average loss in clinical trials" is supported by SURMOUNT-1 among approved medicines in this class, and the weight-loss page scopes it properly, saying tirzepatide "produced larger average weight loss in its clinical trials, at a higher price." The dose range it publishes, 2.5 mg to 15 mg, again matches the trial ladder exactly. What is missing is a citation: no trial, journal or year appears anywhere on the site, so a reader has nothing to check it against. That is unsourced, not wrong.2
Dispensing chain
Who actually fills your prescription
- Manifest Pharmacy
Read the full account
This is one of the fullest supply-chain disclosures we have seen. Rx Com's terms name the dispensing pharmacy, its street address, its telephone number and its opening hours: Manifest Pharmacy, 1018 S. Batesville Road, Greer, South Carolina, on 888-770-4009, weekdays from eight to five Eastern. The prescribing side is named too — MDIntegrations, with its web address — rather than introduced as an example. And then the sentence nobody else writes: you may direct your prescription to any pharmacy of your choosing, with an email address to arrange it before you order. One gap remains. Nothing says whether Manifest makes the medication to order under your prescription or dispenses it ready-made, and no individual clinician is named.
Read on the Rx Com site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Not established in this source review
Certificate of analysis readable
A readable lot report was not verified here
Read the full testing account
No certificate of analysis, potency, purity or sterility result appears anywhere. Its LegitScript certification is real and belongs to this domain — the certificate image loads for Rx Com's website and an invented certificate number returns an error in the same check — which proves a certificate was issued to this site and nothing about what Manifest Pharmacy ships. The more useful thing Rx Com publishes is negative space: no patient count, no satisfaction figure, no testimonial and no before-and-after photograph on its weight-loss pages. The percentages it does shout are the discount card's, a separate business with its own terms, and they describe neither the drug nor its price.
Read on the Rx Com site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
Rx Com's weight-loss FAQ says it currently serves 49 states, all except Alaska, and that some states require a short video visit. The bar at the top of the page reads "Licensed Providers in all 50 States", which describes where its clinicians can practice rather than where the program ships.
Read the full licensing claim
The operating company is named in the footer and the terms — Rx Platform LLC — with arbitration seated in San Francisco under JAMS rules and no state of incorporation published. The clinical network is named as MDIntegrations; no individual prescriber, medical director or advisory panel is.
Named as outside that footprint
Read on the Rx Com site, September 2026.
Regulatory
The FDA warning letter
No FDA warning letter found
Assessment
What holds up, and what does not
- It names the dispensing pharmacy with a street address, phone number and opening hours.
- It names the clinical network too — MDIntegrations — rather than describing it vaguely.
- Its terms say you may send the prescription to any pharmacy you choose, which is close to unique here.
Show 5 more
- Its GLP-1 pages carry no weight-loss percentage and no before-and-after.
- The dose ranges it publishes match the trial ladders exactly, top and bottom, for both molecules.
- "No automatic renewals" is printed under both plans.
- Its LegitScript certification is real and belongs to this domain.
- No FDA warning letter — for Rx Com, for Rx Platform LLC, or for Manifest Pharmacy.
- "Lose pounds of fat every week" heads the signup page. No trial reports a weekly rate, and the trials measured total body weight, not fat.
- No trial is named anywhere, so its one comparative claim about tirzepatide arrives with nothing to check.
- Nothing says whether Manifest Pharmacy makes the medication to order or dispenses it ready-made.
Show 4 more
- No individual clinician is named — MDIntegrations is a network, not a person.
- The discount card's "save up to 90%" shares the brand and the header with a weight-loss program it has nothing to do with.
- No certificate of analysis or batch result is published.
- No state of incorporation is given for Rx Platform LLC.
Verdict
The bottom line
On the two questions this market usually dodges — who makes it, and can I go elsewhere — Rx Com gives the fullest answers we've published. On evidence it is mostly quiet rather than wrong: it describes the molecules accurately, gets the dose ladders right, and cites no trial at all. The exception is "lose pounds of fat every week" on the signup page, which promises more than the trials measured. The one thing to be careful of is arriving from its discount card, because none of those percentages describe this program.
Opens Rx Com's website. A link is not a recommendation to take anything.
Refunds and shipping have separate clocks
The refund policy checked October 13 offers a full refund if a clinician finds treatment inappropriate. Once prescription medicine is dispensed and handed to the carrier, sales are final; damaged or lost orders go through patient support. Canceling a subscription stops future orders rather than proving the dispatched order is refundable. 3
The same policy estimates pharmacy dispatch within two to four business days after approval and delivery in another three to seven business days. It also says refrigerated products are not shipped. For any temperature-sensitive prescription, confirm its storage instructions and packaging with the dispensing pharmacy rather than assuming that general policy describes your product.
Full analysis — 4 more sectionsThe sentence nobody else writes · What it doesn't claim, and the one line that does · The one comparative claim · Careful where you came from
The sentence nobody else writes
From Rx Com's own terms:
"While there may be a preferred pharmacy used, you have the ability to direct your prescription to any pharmacy of your choosing… Please email [support] if you would like to use your own pharmacy before completing your order."
We have read a lot of these documents. That sentence is close to unique.
And it isn't alone. The same terms name the pharmacy outright:
"Prescriptions ordered through the weight-loss program are dispensed by Manifest Pharmacy, 1018 S. Batesville Road, Greer, SC 29650, 888-770-4009, Monday-Friday 8:00am-5:00pm EST."
Plus the prescribing side, MDIntegrations, with its web address. Most sellers name a category and stop.
One gap: nothing says whether Manifest makes the drug to order under your prescription or dispenses it ready-made. That distinction matters, and it's missing.
What it doesn't claim, and the one line that does
Look through the weight-loss page and the terms for a weight-loss percentage, a success rate, a before-and-after or a patient count.
None of them exists. On timing, the page is careful: "In clinical trials of semaglutide and tirzepatide, most weight loss happened over the first year. Results vary from person to person."
The signup page is less careful. Its opening checklist reads:
"Lose pounds of fat every week"
That is the one outcome promise on the site, and it outruns the evidence twice. STEP 1 and SURMOUNT-1 reported average loss over 68 and 72 weeks, not a weekly rate, and they measured total body weight, not fat. 1 2 A reader who does not see pounds come off in a given week has not failed; the sentence promised something no trial measured.
What Rx Com says about the molecules themselves is mechanical and dose-factual:
"Works on both GLP-1 and GIP receptors."
"Your provider sets and adjusts your dose (2.5 mg to 15 mg); your price stays the same."
That second one is worth noticing. SURMOUNT-1 started participants at 2.5 mg and topped out at 15 mg. 2 The semaglutide plan publishes 0.25 mg to 2.4 mg — exactly the ladder STEP 1 used, ending at the maintenance dose it measured. 1
A seller whose published dose range matches the trial is a small signal, and a good one. The usual pattern is a price pegged to a starting dose with nothing published above it.
The one comparative claim
"Dual-action. Largest average loss in clinical trials."
About tirzepatide, and among approved medicines in this class, SURMOUNT-1 supports it. 2 The weight-loss page words it more carefully still: tirzepatide "produced larger average weight loss in its clinical trials, at a higher price." Note the scoping — in its clinical trials, not "of any drug ever". That's the careful version.
No trial is named, though. Nowhere on the site. So a reader has an accurate sentence and no way to verify it.
Careful where you came from
The loudest numbers on Rx Com's website belong to something else entirely:
"Save Up To 90%" · "save up to 80% at the pharmacy with our free Rx Discount Card"
That's a prescription discount card — a separate business with separate terms, sharing the brand and the header. Those percentages describe neither this medication nor its price, and someone arriving from a coupon search is one click from a GLP-1 signup carrying the wrong expectation.
Questions
Frequently asked questions
Which pharmacy fills an Rx Com prescription?
Manifest Pharmacy, at 1018 S. Batesville Road, Greer, South Carolina, on 888-770-4009 weekdays — quoted from Rx Com's own terms, opening hours included, with the doctors' side named too as MDIntegrations. What it doesn't say is whether Manifest makes the medication to order or dispenses it ready-made.
Can I use my own pharmacy?
Rx Com says yes, which is close to unique in this market — its terms tell you to email support before ordering to arrange it. One thing to check first: the plan price includes the medication, so moving the prescription changes what you're paying for.
How much weight will I lose?
Rx Com gives no percentage and no before-and-after. Its weight-loss page says only that in the semaglutide and tirzepatide trials most weight loss happened over the first year, and that results vary. The signup page goes further — "Lose pounds of fat every week" — and that line outruns the trials, which reported average loss over 68 and 72 weeks and measured total body weight, not fat.
Is "largest average loss in clinical trials" true of tirzepatide?
Among approved medicines in this class, yes — SURMOUNT-1 reported the largest mean reduction published. Rx Com scopes the sentence carefully, saying in its clinical trials rather than claiming a universal record. It names no trial, so you'd have to take it on trust from the page itself.
What about the 90% savings I saw?
That's the prescription discount card, a separate business with its own terms that happens to share the brand and the header. It has nothing to do with the GLP-1 program or its pricing. If you arrived from a coupon search, none of those percentages apply here.
Glossary
Key terms
Show definitions
- Titration
- Starting at a low dose and stepping up over weeks to a target. Both major weight-loss trials titrated participants up and measured results at the maintenance dose rather than on the way there.
- Compounded
- Made to order by a pharmacy for an individual patient rather than manufactured and approved as a finished product. Compounded drugs are not FDA-approved and the FDA has not evaluated their safety, effectiveness or quality.
- GIP
- A second gut hormone receptor. Tirzepatide acts on it as well as on the GLP-1 receptor, which is what "dual agonist" means and why its trial results differ from semaglutide's.
Compare
Others selling what Rx Com sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Ranked
The lists Rx Com is on
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Rx Com's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 3 sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, titrated from 0.25 mg to a 2.4 mg maintenance dose. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks, from a 2.5 mg start to 5, 10 and 15 mg maintenance doses. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
- Publisher (2026). Public buyer information checked October 13, 2026. Public primary source. the Rx Com site
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.